Essential Partners’s Summit Therapeutics SMMT Stock Holding History

Essential Partners’s Portfolio SMMT Stock Details SMMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.02K	Buy	+238	New	+$3.56K	﹤0.01%	1614

Other funds holding SMMT

Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $426M AUM 43.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Essential Partners's SMMT Position: Q3 2026 in Review

Essential Partners opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 238 shares worth $4.02K. The stake represents ﹤0.01% of the portfolio and ranks #1614 among its holdings.

37 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

Essential Partners held 238 shares of Summit Therapeutics worth $4.02K as of Q3 2026.
Summit Therapeutics was a new Essential Partners position in Q3 2026.
Summit Therapeutics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1614 holding.
37 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.